“`html
Accenture (ACN) is in discussions about potential merger and acquisition talks, raising mixed reactions from users on X. Many see this as a strategic move amidst a challenging year marked by a raised fiscal guidance but concerns over a reduced forward order book. Recent trading shows 12 transactions by members of Congress involving $ACN stock in the past six months, with 3 purchases and 9 sales.
In the last six months, Accenture insiders conducted 81 trades, all being sales with no purchases. Notably, CEO Julie Sweet sold shares worth approximately $4.7 million. Additionally, institutional investors have shown varied activity, with 1,036 adding shares and 1,210 decreasing their positions. Award payments to Accenture from government contracts reached $2.86 billion in the last year.
Wall Street analysts have issued 10 buy ratings with a median price target of $353 for $ACN in recent months. The largest institutional share changes include Franklin Resources, which added over 3.6 million shares, a 123.4% increase. Notably, analysts recently set price targets ranging from $290 to $360.
“`
